Michael Grissinger - Director at Akari Therapeutics Plc

Issuer-level insider activity

Identity 1 identity field
Entity type
Individual
Source evidence 1 source field
SEC filing history
Open SEC filing history

No buys or sells have been reported by Michael Grissinger since 02 Jun 2025

Reported holdings for Michael Grissinger in Akari Therapeutics Plc

Form 4 holding Director

Akari Therapeutics Plc

Security class
Ordinary Shares, par value $0.0001 per share
Shares / value
20,000,000
Estimated value
Report date
01 Jan 2024
Price
Ownership
Direct
Form 4 holding Director

Akari Therapeutics Plc

Security class
Stock Option (Right to Buy)
Shares / value
5,000,000
Estimated value
Report date
28 Jun 2024
Price
Ownership
Direct
Underlying class
Ordinary Shares, par value $0.0001 per share
Underlying amount

Transaction history for Michael Grissinger in Akari Therapeutics Plc

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .